NasdaqGS - Nasdaq Real Time Price USD
Beam Therapeutics Inc. (BEAM)
17.24
-0.81
(-4.49%)
At close: May 14 at 4:00:01 PM EDT
17.24
0.00
(0.00%)
Pre-Market: 8:48:35 AM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 343,500 | 9 |
| Sales | 155,994 | 11 |
| Net Shares Purchased (Sold) | 187,506 | 20 |
| Total Insider Shares Held | 1.19M | -- |
| % Net Shares Purchased (Sold) | 18.60% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SIMON AMY Officer | Sale at price 17.73 - 18.35 per share. | Direct | 547,835 | Apr 2, 2025 |
| CIARAMELLA GIUSEPPE President | Sale at price 18.35 per share. | Direct | 136,418 | Apr 1, 2025 |
| EVANS JOHN M. Chief Executive Officer | Sale at price 18.35 per share. | Direct | 562,684 | Apr 1, 2025 |
| BELLON CHRISTINE Officer | Sale at price 18.35 per share. | Direct | 104,122 | Apr 1, 2025 |
| CAVANAGH BETHANY J Officer and Treasurer | Sale at price 18.35 per share. | Direct | 55,330 | Apr 1, 2025 |
| CIARAMELLA GIUSEPPE President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 31, 2025 |
| EVANS JOHN M. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 31, 2025 |
| BELLON CHRISTINE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 31, 2025 |
| SIMON AMY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 31, 2025 |
| CAVANAGH BETHANY J Officer and Treasurer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 31, 2025 |
| CAVANAGH BETHANY J Officer and Treasurer | Sale at price 35.00 per share. | Direct | 220,045 | Feb 18, 2025 |
| BELLON CHRISTINE Officer | Conversion of Exercise of derivative security at price 7.22 per share. | Direct | 72,200 | Feb 14, 2025 |
| BELLON CHRISTINE Officer | Sale at price 34.00 per share. | Direct | 340,000 | Feb 14, 2025 |
| EVANS JOHN M. Chief Executive Officer | Conversion of Exercise of derivative security at price 0.67 per share. | Direct | 20,100 | Jan 30, 2025 |
| EVANS JOHN M. Chief Executive Officer | Sale at price 26.75 - 27.28 per share. | Direct | 802,484 | Jan 30, 2025 |
| EVANS JOHN M. Chief Executive Officer | Sale at price 26.75 - 27.28 per share. | Direct | 802,484 | Jan 30, 2025 |
| BELLON CHRISTINE Officer | Sale at price 24.68 per share. | Direct | 30,628 | Jan 2, 2025 |
| CAVANAGH BETHANY J Officer and Treasurer | Sale at price 24.68 per share. | Direct | 27,568 | Jan 2, 2025 |
| EMANY SRAVAN KUMAR Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 31, 2024 |
| CIARAMELLA GIUSEPPE President | Conversion of Exercise of derivative security at price 0.67 per share. | Direct | 35,845 | Dec 17, 2024 |
| CIARAMELLA GIUSEPPE President | Sale at price 26.36 per share. | Direct | 1,347,050 | Nov 6, 2024 |
| CIARAMELLA GIUSEPPE President | Conversion of Exercise of derivative security at price 0.67 - 7.22 per share. | Direct | 83,594 | Oct 14, 2024 |
| CIARAMELLA GIUSEPPE President | Sale at price 26.27 per share. | Direct | 1,342,752 | Oct 14, 2024 |
| BELLON CHRISTINE Officer | Sale at price 23.48 per share. | Direct | 9,040 | Oct 1, 2024 |
| CAVANAGH BETHANY J Officer and Treasurer | Sale at price 23.48 per share. | Direct | 6,785 | Oct 1, 2024 |
| CAVANAGH BETHANY J Officer and Treasurer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 30, 2024 |
| EVANS JOHN M. Chief Executive Officer | Sale at price 24.60 per share. | Direct | 1,476,024 | Sep 30, 2024 |
| SIMON AMY Officer | Sale at price 22.95 - 23.76 per share. | Direct | 29,094 | Jul 2, 2024 |
| EVANS JOHN M. Chief Executive Officer | Sale at price 24.50 per share. | Direct | 1,470,156 | Jun 27, 2024 |
| BURRELL TERRY-ANN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 26, 2024 |
| SIMON AMY Officer | Sale at price 30.54 - 32.13 per share. | Direct | 734,805 | Apr 2, 2024 |
| BURRELL TERRY-ANN Chief Financial Officer | Sale at price 32.12 per share. | Direct | 174,926 | Apr 1, 2024 |
| CIARAMELLA GIUSEPPE President | Sale at price 32.12 per share. | Direct | 145,632 | Apr 1, 2024 |
| EVANS JOHN M. Chief Executive Officer | Sale at price 32.13 per share. | Direct | 581,617 | Apr 1, 2024 |
| BELLON CHRISTINE Officer | Sale at price 32.12 per share. | Direct | 109,240 | Apr 1, 2024 |
| CIARAMELLA GIUSEPPE President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 28, 2024 |
| EVANS JOHN M. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 28, 2024 |
| BELLON CHRISTINE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 28, 2024 |
| SIMON AMY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 28, 2024 |
| BURRELL TERRY-ANN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 28, 2024 |
| EVANS JOHN M. Chief Executive Officer | Sale at price 33.86 per share. | Direct | 2,031,402 | Mar 28, 2024 |
| FMR, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 30.28 - 31.34 per share. | Indirect | 27,545,051 | Feb 14, 2024 |
| EVANS JOHN M. Chief Executive Officer | Sale at price 25.33 per share. | Direct | 1,519,800 | Jan 31, 2024 |
| BELLON CHRISTINE Officer | Sale at price 26.42 per share. | Direct | 50,383 | Jan 3, 2024 |
| BELLON CHRISTINE Officer | Conversion of Exercise of derivative security at price 7.22 per share. | Direct | 72,200 | Nov 20, 2023 |
| BELLON CHRISTINE Officer | Sale at price 30.00 - 31.00 per share. | Direct | 305,000 | Nov 20, 2023 |
| SIMON AMY Officer | Sale at price 18.70 per share. | Direct | 64,478 | Oct 30, 2023 |
| CIARAMELLA GIUSEPPE President | Conversion of Exercise of derivative security at price 0.67 per share. | Direct | 60,903 | Oct 20, 2023 |
| BELLON CHRISTINE Officer | Sale at price 22.85 per share. | Direct | 8,866 | Oct 2, 2023 |
| CIARAMELLA GIUSEPPE President | Conversion of Exercise of derivative security at price 7.22 per share. | Direct | 667,778 | Jul 24, 2023 |
Related Tickers
NTLA Intellia Therapeutics, Inc.
7.88
-5.29%
VERV Verve Therapeutics, Inc.
4.3100
+3.61%
EDIT Editas Medicine, Inc.
1.3800
-8.00%
PRME Prime Medicine, Inc.
1.2100
-4.72%
CRSP CRISPR Therapeutics AG
35.60
-4.35%
CRBU Caribou Biosciences, Inc.
0.8189
+4.61%
FATE Fate Therapeutics, Inc.
0.9600
-4.00%
SRPT Sarepta Therapeutics, Inc.
35.74
-1.27%
DNA Ginkgo Bioworks Holdings, Inc.
7.83
-3.57%
SANA Sana Biotechnology, Inc.
1.7800
-0.84%